Sector
PharmaceuticalsCMP
as on 03 Jul, 2024 12:00:00 AM
Open
₹23.15Prev. Close
₹23.15Turnover(Lac.)
₹43.38Day's High
₹24.6Day's Low
₹23.1552 Week's High
₹27.7552 Week's Low
₹16.05Book Value
₹24.73Face Value
₹10Mkt Cap (₹ Cr.)
59.59P/E
149EPS
0.16Divi. Yield
05 Sep 2023
12:00 AM
BookCloser
5 Sep 2023
12:00 AM
AGM
Announcement Date: 05 Sep, 2023
9 Jun 2024
12:00 AM
Board Meeting
Agenda : Audited Result
| Y/e 31 Mar( In .Cr) | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
|---|---|---|---|---|
Equity Capital | 25 | 25 | 23.36 | 23.36 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 36.43 | 35.35 | 36.51 | 36.19 |
Net Worth | 61.43 | 60.35 | 59.87 | 59.55 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
|---|---|---|---|---|
Revenue | 72.38 | 57.04 | 62.44 | 59.41 |
yoy growth (%) | 26.88 | -8.64 | 5.09 | 14.74 |
Raw materials | -42.91 | -33.6 | -40.42 | -36.01 |
As % of sales | 59.28 | 58.9 | 64.73 | 60.61 |
Employee costs | -6.92 | -4.59 | -5.62 | -4.29 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
|---|---|---|---|---|
Profit before tax | 0.86 | 0.07 | 1.07 | 5.26 |
Depreciation | -2.45 | -2.45 | -2.92 | -1.94 |
Tax paid | -0.33 | -0.14 | -0.28 | -1.25 |
Working capital | 4.97 | -5.1 | -0.87 | 14.24 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 26.88 | -8.64 | 5.09 | 14.74 |
Op profit growth | 23.63 | -7.39 | -37.21 | 30.48 |
EBIT growth | 20.24 | -4.71 | -44.86 | 38.9 |
Net profit growth | -551.24 | -111.05 | -83.64 | 79.07 |
| Particulars (Rupees in Crores.) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
|---|---|---|---|---|---|
Gross Sales | 61.7 | 68.59 | 77.87 | 73.73 | 57.09 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 61.7 | 68.59 | 77.87 | 73.73 | 57.09 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 0.44 | 0.73 | 0.54 | 0.28 | 0.86 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceuticals Industries Ltd SUNPHARMA | 1,528.5 | 120.29 | 3,65,682.64 | 867.6 | 0.89 | 5,536.99 | 98.75 |
Divis Laboratories Ltd DIVISLAB | 4,569.6 | 76.97 | 1,21,312.5 | 531 | 0.66 | 2,259 | 507.93 |
Cipla Ltd CIPLA | 1,486.5 | 32.36 | 1,20,195.02 | 1,038.4 | 0.57 | 3,444.92 | 346.41 |
Zydus Lifesciences Ltd ZYDUSLIFE | 1,105.9 | 31.35 | 1,08,114.81 | 1,405.2 | 0.28 | 3,172.6 | 156.19 |
Dr Reddys Laboratories Ltd DRREDDY | 6,490.25 | 24.48 | 1,06,298.05 | 1,034.8 | 0.63 | 5,081.8 | 1,453.02 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Managing Director
Suraj Zanwar
Company Sec. & Compli. Officer
Munjaji Purbhaji Dhumal
Independent Director
Swati Maheshwari
Director
Paresh Arun Shah
Independent Director
Sunil Kumar
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Cian Healthcare Ltd
Summary
Cian Healthcare Limited was originally incorporated as a private limited company with the name of Cian Healthcare Private Limited on January 07, 2003. Subsequently, the Company was converted into a public limited company pursuant to a special resolution passed by the shareholders dated November 19, 2018 and the name of the Company was changed to Cian Healthcare Limited to reflect the legal status of the Company pursuant to a fresh certificate of incorporation granted by the Registrar of Companies, Pune dated November 30, 2018. The Company is a WHO-GMP & ISO-9001:2015 certified transnational manufacturing Company with wide range of Pharmaceutical, Nutraceutical, Ayurvedic, Cosmeceuticals, Sexual Wellness and Food supplement products. The Company has a full-fledged F & D and regulatory department. The Company complies with the standard manufacturing practices as laid down by the World Health Organization and is also certified by the Food and Drug Control Administration The Company develops, manufactures and commercializes pharmaceutical products including sales, marketing, quality assurance, distribution, compliance and regulatory aspects under 12 therapeutic segments like Orthopaedics, Gynaecology, Paediatrics, Cardiac, Diabetic, Dermatology, Pain Management, Antibiotics, Neuro, Critical Care, Gastro-Intestinal and Nutraceuticals, alongwith 10 sales division focused on developing and growing its engagements in specialist and super specialist division. The company works under d
Read More
What is the Cian Healthcare Ltd share price today?
The Cian Healthcare Ltd shares price on nse is Rs.₹23.84 today.
What is the Market Cap of Cian Healthcare Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Cian Healthcare Ltd is ₹59.59 Cr. as of 03 Jul ‘24
What is the PE and PB ratio of Cian Healthcare Ltd?
The PE and PB ratios of Cian Healthcare Ltd is 149 and 0.96 as of 03 Jul ‘24
What is the 52 Week High and Low of Cian Healthcare Ltd?
The 52-week high/low is the highest and lowest price at which a Cian Healthcare Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Cian Healthcare Ltd is ₹16.05 and ₹27.75 as of 03 Jul ‘24
What is the CAGR of Cian Healthcare Ltd?
Cian Healthcare Ltd's CAGR for 5 Years at -16.46%, 3 Years at 0.14%, 1 Year at -12.21%, 6 Month at 35.38%, 3 Month at 5.42% and 1 Month at 1.54%.
What is the shareholding pattern of Cian Healthcare Ltd?
The shareholding pattern of Cian Healthcare Ltd is as follows:
Promoters - 27.10 %
Institutions - 0.00 %
Public - 72.90 %
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
